Michael James Elliott Immunovant, Inc. (IMVT) insider trading activity

IMVT Quotes by TradingView

Michael James Elliott is Chief Scientific Officer of Immunovant, Inc.. Currently has a direct ownership of 97,600 shares of IMVT, which is worth approximately $2.68 Million. The most recent transaction as insider was on Mar 19, 2021, when has been sold 97,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.6K
0% 3M change
0% 12M change
Total Value Held $2.68 Million

Michael James Elliott Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2021
BUY
Grant, award, or other acquisition
-
97,600 Added 50.0%
97,600 Common Stock
MJE

Michael James Elliott

Chief Scientific Officer
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMVT